MSTN and chronic obstructive pulmonary disease: The activation of myostatin by FHL1 may help to explain the increase in FHL1 following sciatic nerve section [17] and the association of FHL1 with weakness in COPD patients [19] as myostatin expression increases in both situations [33,34].